• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

8
results for

"Growth"

Filter

Article category

Keywords

Publication year

Authors

"Growth"

Original Article

[English]
ABSTRACT Objectives:

This study investigated the relationship between the stimulated peak growth hormone (PGH) level and comprehensive metabolic markers for glucose and lipid metabolism, and liver steatosis in prepubertal children with GH deficiency (GHD).

Methods:

Sixty-nine prepubertal children with GHD were divided into overweight/obesity (body mass index [BMI]≥85th percentile) and normal BMI groups. The associations between PGH level and metabolic parameters including homeostatic model assessment-insulin resistance (HOMA-IR), lipid profiles, AST, and ALT were evaluated.

Results:

The LDL cholesterol level was significantly higher in the overweight/obesity group than in the normal BMI group. PGH level was negatively associated with the BMI SD score (SDS) (r=−0.26, P=0.029) and ALT (r=−0.36, P=0.004) levels, whereas it was positively associated with the HDL-cholesterol (HDL-C) level (r=0.38, P=0.002). In multivariate analyses, PGH level was positively associated with HDL-C level (P=0.002) and negatively associated with ALT level (P=0.028) after adjusting for age, sex, BMI SDS, HOMA-IR, and TG level.

Conclusion:

PGH level in pre-pubertal children with GHD was positively and negatively associated with HDL-C and ALT, respectively, even if they were within normal range, regardless of BMI.

  • 82 View
  • 0 Download

Review Article

[Korean]
Approach to Short Stature in Children and Adolescent
Ewha Med J 2021;44(4):111-116.   Published online October 31, 2021
DOI: https://doi.org/10.12771/emj.2021.44.4.111

Growth represents a sentinel for general health state in children and adolescent. Linear growth in children and adolescent is a complex process influenced by numerous factors including genetic, prenatal, postnatal, and environmental factors. When children less than 2 standard deviation score below the average height for age and sex, they are considered as short stature. Accurate measurement of body profile and determination of height velocity over time are fundamental step. Whether the growth pattern is appropriate or deviated from standardized growth chart is a key point in approaching to short stature in children. Evaluation includes a detailed past medical and family history, physical examination, laboratory test and radiologic evaluation. Recent advances in genetic approaches are allowing for improved diagnosis for idiopathic short stature and various genetic syndromes. Growth hormone is the main treatment option for short stature. It is generally safe but has potential side effects. Individualized growth hormone treatment should be initiated under consideration of both efficacy and safety by pediatric endocrinologists. Early diagnosis and prompt initiation of treatment result in a good prognosis. This article reviews an overview of the diagnostic approach to children and adolescents with short stature, and summarizes etiologies and growth hormone treatment.

  • 139 View
  • 10 Download

Original Article

[English]
Changes in Serum Concentrations of Insulin-like Growth Factor Binding Protein-3 after General Anesthesia Using Propofol or Isoflurane
Jae Hee Woo, Jong Hak Kim, Hee Jung Baik, Minjin Lee, Youn Jin Kim
Ewha Med J 2018;41(1):8-12.   Published online January 31, 2018
DOI: https://doi.org/10.12771/emj.2018.41.1.8
Objectives

The insulin-like growth factor binding proteins (IGFBP) regulate the bioavailability and bioactivity of insulin-like growth factor. We aimed to evaluate whether the IGFBP-3 level undergo major changes during perioperative periods according to the different kind of anesthetic agents.

Methods

Eighteen adults scheduled for elective total abdominal hysterectomy were enrolled. The patients were randomly assigned to have either propofol or isoflurane for maintenance of general anesthesia. A venous sample was taken for analysis of IGFBP-3 at the following time points: before induction, at the time of peritoneal closure, 1 hour after extubation at recovery room, and 2 and 5 postoperative days. The samples were analyzed by enzyme linked immunosolvent assay.

Results

Demographic data were similar between groups. In the both groups, the IGFBP-3 concentration decreased after anesthesia induction, reaching a nadir at the time of peritoneal closure without a significant difference between groups. In analysis between groups, the IGFBP-3 concentration in the isoflurane group on the postoperative 5th day was recovered to preoperative value and significantly higher than that in the propofol group (P<0.05).

Conclusion

This is the first study to show that the anesthetics used for general anesthesia affect the IGFBP-3 level during perioperative periods. The decrease of IGFBP-3 level following anesthesia induction in the isoflurane group was recovered to preoperative value, whereas that observed in the propofol group was not recovered on the postoperative 5th day. Further study is needed to establish the definitive effect of general anesthetics on IGFBP-3 and provide a comprehensive interpretation.

  • 59 View
  • 0 Download

Case Report

[English]
A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement
Min Hwan Kim, Yehyun Park, Hye Jung Park, Ah-young Ji, Changho Song, Moo-Nyun Jin, Young Ju Kim, Sun Wook Kim, Jung-Hee Lee, In-Soo Kim, Hye Ryun Kim, Joohang Kim, Byoung Chul Cho
Ewha Med J 2014;37(1):46-51.   Published online March 25, 2014
DOI: https://doi.org/10.12771/emj.2014.37.1.46

The rearrangement of c-ros oncogene 1 (ROS1) has been recently identified as an important molecular target in non small cell lung cancer (NSCLC). ROS1 rearrangement and epidermal growth factor receptor (EGFR) mutation were mutually exclusive each other in previous studies, and the clinical implication of co-existence of the two genetic alterations has not been determined. We report a case of 46-year-old female never-smoker NSCLC patient whose tumor harbored ROS1 rearrangement and EGFR mutation concomitantly. She had undergone curative surgery for stage IIIA NSCLC, and the recurrence in left pleura and brain occurred at 2 years after the surgery. She received several lines of chemotherapy including docetaxel plus carboplatin, erlotinib, pemetrexed, and gemcitabine. Erlotinib therapy showed a favorable treatment response with progression-free survival of 9.5 months and partial response of tumor on radiologic evaluations. This case represents a successful erlotinib treatment in a NSCLC patient with concurrent ROS1 rearrangement and EGFR mutation.

  • 72 View
  • 0 Download
Original Articles
[English]
Cord Blood Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor in Preterm Infants with Maternal Preeclampsia
Jiyoung Kim, Sujin Cho, Young ju Kim, Hye Sook Park, Eun-Hee Ha, Eun Ae Park
Ewha Med J 2013;36(2):118-125.   Published online September 26, 2013
DOI: https://doi.org/10.12771/emj.2013.36.2.118
Objectives

The purpose of this study was to investigate the relationship of cord blood levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in preterm infants with maternal preeclampsia.

Methods

Thirty six preterm infants born at Ewha Womans University Mokdong Hospital from January 2006 to August 2006 were studied after prior parental consent at mid-pregnancy. sFlt-1, PlGF, and VEGF levels in the cord blood of preterm neonate, with or without maternal preeclampsia, were measured using enzyme-linked immunosorbent assay.

Results

There was no difference in sFlt-1 between infants with and without maternal preeclampsia. Infants with maternal preeclampsia had significantly lower PlGF levels (P=0.035) and higher sFlt-1/PlGF ratio (P=0.080) with borderline significance. Cord blood VEGF levels were not related to maternal preeclampsia. Infants with maternal preeclampsia had lower birth weight (P=0.030), lower neonatal platelet count without statistical significance (P=0.064) and more likely to be small for gestational age (P=0.057). Neonatal platelet count was significantly correlated with cord blood PlGF levels (r=0.674, P=0.032).

Conclusion

Increased sFlt-1/PlGF ratio and decreased PlGF may not only be related to the pathophysiology of maternal preeclampsia but also affect the neonatal platelet count and birth weight.

Citations

Citations to this article as recorded by  
  • The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
    Lisa Middendorf, Alexandra Gellhaus, Antonella Iannaccone, Angela Köninger, Anne-Kathrin Dathe, Ivo Bendix, Beatrix Reisch, Ursula Felderhoff-Mueser, Britta Huening
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • 110 View
  • 0 Download
  • 1 Crossref
[English]
Effects of Hypoxia on Vascular Endothelial Growth Factor and Fibroblast Growth Factor Expression in Eutopic Endometrium with Endometriosis
Kyung Ah Jeong, Shun Hee Chun, Jeong-Mi Yoon
Ihwa Ŭidae chi 2008;31(1):15-20.   Published online June 30, 2008
DOI: https://doi.org/10.12771/emj.2008.31.1.15
Objectives

This study was performed to investigate the functional roles of hypoxia and HIF-1 α, leading to expression of VEGF and FGF in the pathogenesis of endometriosis.

Methods

From September 2005 to february 2006, endometrial stromal cells were obtained from the patients with or without endometrosis at the Department of Obstetrics and Gynecology of Ewha Womans University Dongdaemun Hospital. These cells were cultured and treated with 100uM desferrioxamine (DFO) for 0hr and 2hr. After the extraction of total RNA, RT-PCR was performed and the expression level of HIF-1 α, VEGF and FGF mRNA were measured by β-actin as 1. Statistical analysis was performed by Wilcoxon signed rank test and Mann-Whitney U test (SPSS 12.0 version). A p value of 0.05 was considered as the limit for statistical significance.

Results

Chemical hypoxia condition with DFO in normal endometrium results m the up-regulation of HIF-1 α, but it was significantly decreased in the eutopic endometrium of the patients with endometriosis. The expression of VEGF in normal control group was not changed, but it was increased in endometriosis group under chemical hypoxia. Hypoxia with DFO induced the overexpression of FGF in endometriosis group, compared that it was slightly decreased in normal endometrium.

Conclusion

Hypoxia and subsequent production of HIF-1 α might regulate angiogenesis by the expression of VEGF and FGF, that is related to the pathogenesis of endometriosis. However, further studies are warranted to confirm.

  • 55 View
  • 0 Download
[English]
Weight Change in Young Children after Adenotonsillectomy
Chun Dong Kim, Sung-Wan Byun
Ihwa Ŭidae chi 2001;24(1):11-14.   Published online March 31, 2001
DOI: https://doi.org/10.12771/emj.2001.24.1.11
Objectives

There are controversial evidences that children gain weight to a significant extent after adenotonsillectomy, usually associated with a general improvement in health. This study is aimed to evaluate the growth disturbance in children with adenotonsillar hypertrophy and the effect of adenotonsillectomy on subsequent growth in them.

Methods

Ninty-one children adenotonsillectomized had their weights recorded preoperatively, and reweighted twelve months after surgery.

Results

The results showed the patients were generally not underweighted before surgery. Their median weight was on the 59.5 percentile. Their weights after surgery had increased by an average of 20 percent over what would have been expected. This increase in weight was not confined to underweight children but to the entire group.

Conclusion

Upper airway obstruction resulting from adenotonsillar hypertrophy might be suspected as a possible cause in the workup of children with suboptimum growth.

  • 56 View
  • 0 Download
[English]
The Expression of bFGF m-RNA in the Gastric Cancer Tissues
Young-Woo Kim
Ihwa Ŭidae chi 1999;22(1):17-21.   Published online March 30, 1999
DOI: https://doi.org/10.12771/emj.1999.22.1.17
Backgrounds

The production of basic fibroblast growth factor(bFGF), which is known to have strong angiogenic activity in gastric cancer, was evaluated.

Methods

Using Alkaline phosphoatase-labelled, synthetic oligonucleotide probe of bFGF genes, the expression of the gene was evaluated with in situ hybridization method in 9 fresh advanced gastric cancer tissues.

Results

In situ Hybridization of bFGF mRNA showed positive reaction in 8 of 9 patients.

Conclusions

In view of profuse expression of angiogenic growth factor, future therapeutic targeting for angiogenesis could be reasonable in patients with gastric cancer.

  • 52 View
  • 0 Download
TOP